Literature DB >> 25225673

Mucosal-associated invariant T cell deficiency in systemic lupus erythematosus.

Young-Nan Cho1, Seung-Jung Kee2, Tae-Jong Kim1, Hye Mi Jin1, Moon-Ju Kim1, Hyun-Ju Jung1, Ki-Jeong Park1, Sung-Ji Lee1, Shin-Seok Lee1, Yong-Soo Kwon3, Hae Jin Kee4, Nacksung Kim5, Yong-Wook Park6.   

Abstract

Mucosal-associated invariant T (MAIT) cells contribute to protection against certain microorganism infections and play an important role in mucosal immunity. However, the role of MAIT cells remains enigmatic in autoimmune diseases. In this study, we examined the level and function of MAIT cells in patients with rheumatic diseases. MAIT cell, cytokine, and programmed death-1 (PD-1) levels were measured by flow cytometry. Circulating MAIT cell levels were significantly reduced in systemic lupus erythematosus (SLE) and rheumatoid arthritis patients. In particular, this MAIT cell deficiency was more prominent in CD8(+) and double-negative T cell subsets, and significantly correlated with disease activity, such as SLE disease activity index and 28-joint disease activity score. Interestingly, MAIT cell frequency was significantly correlated with NKT cell frequency in SLE patients. IFN-γ production in MAIT cells was impaired in SLE patients, which was due to an intrinsic defect in the Ca(2+)/calcineurin/NFAT1 signaling pathway. In SLE patients, MAIT cells were poorly activated by α-galactosylceramide-stimulated NKT cells, thereby showing the dysfunction between MAIT cells and NKT cells. Notably, an elevated expression of PD-1 in MAIT cells and NKT cells was associated with SLE. In rheumatoid arthritis patients, MAIT cell levels were significantly higher in synovial fluid than in peripheral blood. Our study primarily demonstrates that MAIT cells are numerically and functionally deficient in SLE. In addition, we report a novel finding that this MAIT cell deficiency is associated with NKT cell deficiency and elevated PD-1 expression. These abnormalities possibly contribute to dysregulated mucosal immunity in SLE.
Copyright © 2014 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25225673     DOI: 10.4049/jimmunol.1302701

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  73 in total

Review 1.  PD-1 immunobiology in systemic lupus erythematosus.

Authors:  Colleen S Curran; Sarthak Gupta; Ignacio Sanz; Elad Sharon
Journal:  J Autoimmun       Date:  2018-11-03       Impact factor: 7.094

Review 2.  The role of mucosal-associated invariant T cells in infectious diseases.

Authors:  Emily B Wong; Thumbi Ndung'u; Victoria O Kasprowicz
Journal:  Immunology       Date:  2016-10-26       Impact factor: 7.397

3.  Both mucosal-associated invariant and natural killer T-cell deficiency in multiple myeloma can be countered by PD-1 inhibition.

Authors:  Mérédis Favreau; Koen Venken; Sylvia Faict; Ken Maes; Kim De Veirman; Elke De Bruyne; Xavier Leleu; Louis Boon; Dirk Elewaut; Karin Vanderkerken; Eline Menu
Journal:  Haematologica       Date:  2017-04-06       Impact factor: 9.941

Review 4.  The burgeoning family of unconventional T cells.

Authors:  Dale I Godfrey; Adam P Uldrich; James McCluskey; Jamie Rossjohn; D Branch Moody
Journal:  Nat Immunol       Date:  2015-11       Impact factor: 25.606

5.  Autoimmunity: Impaired mucosal immunity in patients with SLE.

Authors:  João H Duarte
Journal:  Nat Rev Rheumatol       Date:  2014-09-30       Impact factor: 20.543

Review 6.  What rheumatologists need to know about innate lymphocytes.

Authors:  Mark A Exley; George C Tsokos; Kingston H G Mills; Dirk Elewaut; Ben Mulhearn
Journal:  Nat Rev Rheumatol       Date:  2016-09-02       Impact factor: 20.543

7.  Human Tissue-Resident Mucosal-Associated Invariant T (MAIT) Cells in Renal Fibrosis and CKD.

Authors:  Becker M P Law; Ray Wilkinson; Xiangju Wang; Katrina Kildey; Kurt Giuliani; Kenneth W Beagley; Jacobus Ungerer; Helen Healy; Andrew J Kassianos
Journal:  J Am Soc Nephrol       Date:  2019-06-11       Impact factor: 10.121

8.  Deficiency of Mucosal-Associated Invariant T Cells in TCRJα18 Germline Knockout Mice.

Authors:  Jinhai Xie; Yun Pan; Huishan Tao; Peng Wang; Yongping Chen; Jimin Gao; Xiao-Ping Zhong
Journal:  Immunohorizons       Date:  2019-06-11

9.  Activation and Impaired Tumor Necrosis Factor-α Production of Circulating Mucosal-Associated Invariant T Cells in Patients with Trauma.

Authors:  Young-Goun Jo; Hye-Mi Jin; Young-Nan Cho; Jung-Chul Kim; Seung-Jung Kee; Yong-Wook Park
Journal:  J Innate Immun       Date:  2019-05-14       Impact factor: 7.349

10.  Cytotoxic and regulatory roles of mucosal-associated invariant T cells in type 1 diabetes.

Authors:  Ophélie Rouxel; Jennifer Da Silva; Lucie Beaudoin; Isabelle Nel; Céline Tard; Lucie Cagninacci; Badr Kiaf; Masaya Oshima; Marc Diedisheim; Marion Salou; Alexandra Corbett; Jamie Rossjohn; James McCluskey; Raphael Scharfmann; Manuela Battaglia; Michel Polak; Olivier Lantz; Jacques Beltrand; Agnès Lehuen
Journal:  Nat Immunol       Date:  2017-10-09       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.